Skip to main content
Top
Published in: BMC Medical Genetics 1/2010

Open Access 01-12-2010 | Research article

Variable number of tandem repeat polymorphisms of the interleukin-1 receptor antagonist gene IL-1RN: a novel association with the athlete status

Authors: Sabina Cauci, Manuela Di Santolo, Kelli K Ryckman, Scott M Williams, Giuseppe Banfi

Published in: BMC Medical Genetics | Issue 1/2010

Login to get access

Abstract

Background

The interleukin-1 (IL-1) family of cytokines is involved in the inflammatory and repair reactions of skeletal muscle during and after exercise. Specifically, plasma levels of the IL-1 receptor antagonist (IL-1ra) increase dramatically after intense exercise, and accumulating evidence points to an effect of genetic polymorphisms on athletic phenotypes. Therefore, the IL-1 family cytokine genes are plausible candidate genes for athleticism. We explored whether IL-1 polymorphisms are associated with athlete status in European subjects.

Methods

Genomic DNA was obtained from 205 (53 professional and 152 competitive non-professional) Italian athletes and 458 non-athlete controls. Two diallelic polymorphisms in the IL-1β gene (IL-1B) at -511 and +3954 positions, and a variable number tandem repeats (VNTR) in intron 2 of the IL-1ra gene (IL-1RN) were assessed.

Results

We found a 2-fold higher frequency of the IL-1RN 1/2 genotype in athletes compared to non-athlete controls (OR = 1.93, 95% CI = 1.37-2.74, 41.0% vs. 26.4%), and a lower frequency of the 1/1 genotype (OR = 0.55, 95% CI = 0.40-0.77, 43.9% vs. 58.5%). Frequency of the IL-1RN 2/2 genotype did not differ between groups. No significant differences between athletes and controls were found for either -511 or +3954 IL-1B polymorphisms. However, the haplotype (-511)C-(+3954)T-(VNTR)2 was 3-fold more frequent in athletes than in non-athletes (OR = 3.02, 95% CI = 1.16-7.87). Interestingly, the IL-1RN 1/2 genotype was more frequent in professional than in non-professional athletes (OR = 1.92, 95% CI = 1.02-3.61, 52.8% vs. 36.8%).

Conclusions

Our study found that variants at the IL-1ra gene associate with athletic status. This confirms the crucial role that cytokine IL-1ra plays in human physical exercise. The VNTR IL-1RN polymorphism may have implications for muscle health, performance, and/or recovery capacities. Further studies are needed to assess these specific issues. As VNTR IL-1RN polymorphism is implicated in several disease conditions, athlete status may constitute a confounding variable that will need to be accounted for when examining associations of this polymorphism with disease risk.
Appendix
Available only for authorised users
Literature
1.
go back to reference Petersen AM, Pedersen BK: The anti-inflammatory effect of exercise. J Appl Physiol. 2005, 98: 1154-1162. 10.1152/japplphysiol.00164.2004.CrossRefPubMed Petersen AM, Pedersen BK: The anti-inflammatory effect of exercise. J Appl Physiol. 2005, 98: 1154-1162. 10.1152/japplphysiol.00164.2004.CrossRefPubMed
2.
go back to reference Nieman DC, Henson DA, Smith LL, Utter AC, Vinci DM, Davis JM, Kaminsky DE, Shute M: Cytokine changes after a marathon race. J Appl Physiol. 2001, 91: 109-114.PubMed Nieman DC, Henson DA, Smith LL, Utter AC, Vinci DM, Davis JM, Kaminsky DE, Shute M: Cytokine changes after a marathon race. J Appl Physiol. 2001, 91: 109-114.PubMed
3.
go back to reference Gleeson M: Immune function in sport and exercise. J Appl Physiol. 2007, 103: 693-699. 10.1152/japplphysiol.00008.2007.CrossRefPubMed Gleeson M: Immune function in sport and exercise. J Appl Physiol. 2007, 103: 693-699. 10.1152/japplphysiol.00008.2007.CrossRefPubMed
4.
go back to reference Tidball JG: Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol. 2005, 288: R345-353.CrossRefPubMed Tidball JG: Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol. 2005, 288: R345-353.CrossRefPubMed
5.
go back to reference Peake JM, Suzuki K, Hordern M, Wilson G, Nosaka K, Coombes JS: Plasma cytokine changes in relation to exercise intensity and muscle damage. Eur J Appl Physiol. 2005, 95: 514-521. 10.1007/s00421-005-0035-2.CrossRefPubMed Peake JM, Suzuki K, Hordern M, Wilson G, Nosaka K, Coombes JS: Plasma cytokine changes in relation to exercise intensity and muscle damage. Eur J Appl Physiol. 2005, 95: 514-521. 10.1007/s00421-005-0035-2.CrossRefPubMed
6.
go back to reference Dinarello CA: Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009, 27: 519-550. 10.1146/annurev.immunol.021908.132612.CrossRefPubMed Dinarello CA: Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009, 27: 519-550. 10.1146/annurev.immunol.021908.132612.CrossRefPubMed
7.
go back to reference Dinarello CA: Interleukin-1beta and the autoinflammatory diseases. N Engl J Med. 2009, 360: 2467-2470. 10.1056/NEJMe0811014.CrossRefPubMed Dinarello CA: Interleukin-1beta and the autoinflammatory diseases. N Engl J Med. 2009, 360: 2467-2470. 10.1056/NEJMe0811014.CrossRefPubMed
8.
go back to reference Fielding RA, Manfredi TJ, Ding W, Fiatarone MA, Evans WJ, Cannon JG: Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle. Am J Physiol. 1993, 265: R166-172.PubMed Fielding RA, Manfredi TJ, Ding W, Fiatarone MA, Evans WJ, Cannon JG: Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle. Am J Physiol. 1993, 265: R166-172.PubMed
9.
go back to reference Mahoney DJ, Safdar A, Parise G, Melov S, Fu M, MacNeil L, Kaczor J, Payne ET, Tarnopolsky MA: Gene expression profiling in human skeletal muscle during recovery from eccentric exercise. Am J Physiol Regul Integr Comp Physiol. 2008, 294: R1901-1910.CrossRefPubMed Mahoney DJ, Safdar A, Parise G, Melov S, Fu M, MacNeil L, Kaczor J, Payne ET, Tarnopolsky MA: Gene expression profiling in human skeletal muscle during recovery from eccentric exercise. Am J Physiol Regul Integr Comp Physiol. 2008, 294: R1901-1910.CrossRefPubMed
10.
go back to reference Dennis RA, Trappe TA, Simpson P, Carroll C, Huang BE, Nagarajan R, Bearden E, Gurley C, Duff GW, Evans WJ, et al: Interleukin-1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise. J Physiol. 2004, 560: 617-626. 10.1113/jphysiol.2004.067876.CrossRefPubMedPubMedCentral Dennis RA, Trappe TA, Simpson P, Carroll C, Huang BE, Nagarajan R, Bearden E, Gurley C, Duff GW, Evans WJ, et al: Interleukin-1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise. J Physiol. 2004, 560: 617-626. 10.1113/jphysiol.2004.067876.CrossRefPubMedPubMedCentral
11.
go back to reference Duff GW: Evidence for genetic variation as a factor in maintaining health. Am J Clin Nutr. 2006, 83: 431S-435S.PubMed Duff GW: Evidence for genetic variation as a factor in maintaining health. Am J Clin Nutr. 2006, 83: 431S-435S.PubMed
12.
go back to reference Dinarello CA: Biologic basis for interleukin-1 in disease. Blood. 1996, 87: 2095-2147.PubMed Dinarello CA: Biologic basis for interleukin-1 in disease. Blood. 1996, 87: 2095-2147.PubMed
13.
go back to reference Gallucci S, Provenzano C, Mazzarelli P, Scuderi F, Bartoccioni E: Myoblasts produce IL-6 in response to inflammatory stimuli. Int Immunol. 1998, 10: 267-273. 10.1093/intimm/10.3.267.CrossRefPubMed Gallucci S, Provenzano C, Mazzarelli P, Scuderi F, Bartoccioni E: Myoblasts produce IL-6 in response to inflammatory stimuli. Int Immunol. 1998, 10: 267-273. 10.1093/intimm/10.3.267.CrossRefPubMed
14.
go back to reference Dewberry R, Holden H, Crossman D, Francis S: Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol. 2000, 20: 2394-2400.CrossRefPubMed Dewberry R, Holden H, Crossman D, Francis S: Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol. 2000, 20: 2394-2400.CrossRefPubMed
16.
go back to reference Hurme M, Santtila S: IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol. 1998, 28: 2598-2602. 10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K.CrossRefPubMed Hurme M, Santtila S: IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol. 1998, 28: 2598-2602. 10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K.CrossRefPubMed
17.
go back to reference Buchs N, di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P: IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun. 2001, 2: 222-228. 10.1038/sj.gene.6363766.CrossRefPubMed Buchs N, di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P: IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun. 2001, 2: 222-228. 10.1038/sj.gene.6363766.CrossRefPubMed
18.
go back to reference Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG, Pena AS: Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol. 1995, 102: 379-383.CrossRefPubMedPubMedCentral Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG, Pena AS: Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol. 1995, 102: 379-383.CrossRefPubMedPubMedCentral
19.
go back to reference El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000, 404: 398-402. 10.1038/35006081.CrossRefPubMed El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000, 404: 398-402. 10.1038/35006081.CrossRefPubMed
20.
go back to reference Santtila S, Savinainen K, Hurme M: Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 1998, 47: 195-198. 10.1046/j.1365-3083.1998.00300.x.CrossRefPubMed Santtila S, Savinainen K, Hurme M: Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 1998, 47: 195-198. 10.1046/j.1365-3083.1998.00300.x.CrossRefPubMed
21.
go back to reference Strandberg L, Lorentzon M, Hellqvist A, Nilsson S, Wallenius V, Ohlsson C, Jansson JO: Interleukin-1 system gene polymorphisms are associated with fat mass in young men. J Clin Endocrinol Metab. 2006, 91: 2749-2754. 10.1210/jc.2005-2786.CrossRefPubMed Strandberg L, Lorentzon M, Hellqvist A, Nilsson S, Wallenius V, Ohlsson C, Jansson JO: Interleukin-1 system gene polymorphisms are associated with fat mass in young men. J Clin Endocrinol Metab. 2006, 91: 2749-2754. 10.1210/jc.2005-2786.CrossRefPubMed
22.
go back to reference Rafiq S, Stevens K, Hurst AJ, Murray A, Henley W, Weedon MN, Bandinelli S, Corsi AM, Guralnik JM, Ferrucci L, et al: Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun. 2007, 8: 344-351. 10.1038/sj.gene.6364393.CrossRefPubMed Rafiq S, Stevens K, Hurst AJ, Murray A, Henley W, Weedon MN, Bandinelli S, Corsi AM, Guralnik JM, Ferrucci L, et al: Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun. 2007, 8: 344-351. 10.1038/sj.gene.6364393.CrossRefPubMed
23.
go back to reference Isoda K, Ohsuzu F: The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism. J Atheroscler Thromb. 2006, 13: 21-30.CrossRefPubMed Isoda K, Ohsuzu F: The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism. J Atheroscler Thromb. 2006, 13: 21-30.CrossRefPubMed
24.
go back to reference Achyut BR, Srivastava A, Bhattacharya S, Mittal B: Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians. Clin Chim Acta. 2007, 377: 163-169. 10.1016/j.cca.2006.09.012.CrossRefPubMed Achyut BR, Srivastava A, Bhattacharya S, Mittal B: Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians. Clin Chim Acta. 2007, 377: 163-169. 10.1016/j.cca.2006.09.012.CrossRefPubMed
25.
go back to reference Marculescu R, Endler G, Schillinger M, Iordanova N, Exner M, Hayden E, Huber K, Wagner O, Mannhalter C: Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes. 2002, 51: 3582-3585. 10.2337/diabetes.51.12.3582.CrossRefPubMed Marculescu R, Endler G, Schillinger M, Iordanova N, Exner M, Hayden E, Huber K, Wagner O, Mannhalter C: Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes. 2002, 51: 3582-3585. 10.2337/diabetes.51.12.3582.CrossRefPubMed
26.
go back to reference Blakemore AI, Cox A, Gonzalez AM, Maskil JK, Hughes ME, Wilson RM, Ward JD, Duff GW: Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet. 1996, 97: 369-374. 10.1007/BF02185776.CrossRefPubMed Blakemore AI, Cox A, Gonzalez AM, Maskil JK, Hughes ME, Wilson RM, Ward JD, Duff GW: Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet. 1996, 97: 369-374. 10.1007/BF02185776.CrossRefPubMed
27.
go back to reference Reiner AP, Wurfel MM, Lange LA, Carlson CS, Nord AS, Carty CL, Rieder MJ, Desmarais C, Jenny NS, Iribarren C, et al: Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arterioscler Thromb Vasc Biol. 2008, 28: 1407-1412. 10.1161/ATVBAHA.108.167437.CrossRefPubMedPubMedCentral Reiner AP, Wurfel MM, Lange LA, Carlson CS, Nord AS, Carty CL, Rieder MJ, Desmarais C, Jenny NS, Iribarren C, et al: Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arterioscler Thromb Vasc Biol. 2008, 28: 1407-1412. 10.1161/ATVBAHA.108.167437.CrossRefPubMedPubMedCentral
28.
go back to reference Paardt van der M, Crusius JB, Garcia-Gonzalez MA, Baudoin P, Kostense PJ, Alizadeh BZ, Dijkmans BA, Pena AS, Horst-Bruinsma van der IE: Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford). 2002, 41: 1419-1423. 10.1093/rheumatology/41.12.1419.CrossRef Paardt van der M, Crusius JB, Garcia-Gonzalez MA, Baudoin P, Kostense PJ, Alizadeh BZ, Dijkmans BA, Pena AS, Horst-Bruinsma van der IE: Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford). 2002, 41: 1419-1423. 10.1093/rheumatology/41.12.1419.CrossRef
29.
go back to reference Rider LG, Artlett CM, Foster CB, Ahmed A, Neeman T, Chanock SJ, Jimenez SA, Miller FW: Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies. Clin Exp Immunol. 2000, 121: 47-52. 10.1046/j.1365-2249.2000.01266.x.CrossRefPubMedPubMedCentral Rider LG, Artlett CM, Foster CB, Ahmed A, Neeman T, Chanock SJ, Jimenez SA, Miller FW: Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies. Clin Exp Immunol. 2000, 121: 47-52. 10.1046/j.1365-2249.2000.01266.x.CrossRefPubMedPubMedCentral
30.
go back to reference Walley AJ, Aucan C, Kwiatkowski D, Hill AV: Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study. Eur J Hum Genet. 2004, 12: 132-138. 10.1038/sj.ejhg.5201084.CrossRefPubMed Walley AJ, Aucan C, Kwiatkowski D, Hill AV: Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study. Eur J Hum Genet. 2004, 12: 132-138. 10.1038/sj.ejhg.5201084.CrossRefPubMed
31.
go back to reference Cauci S, Di Santolo M, Casabellata G, Ryckman K, Williams SM, Guaschino S: Association of interleukin-1beta and interleukin-1 receptor antagonist polymorphisms with bacterial vaginosis in non-pregnant Italian women. Mol Hum Reprod. 2007, 13: 243-250. 10.1093/molehr/gam002.CrossRefPubMed Cauci S, Di Santolo M, Casabellata G, Ryckman K, Williams SM, Guaschino S: Association of interleukin-1beta and interleukin-1 receptor antagonist polymorphisms with bacterial vaginosis in non-pregnant Italian women. Mol Hum Reprod. 2007, 13: 243-250. 10.1093/molehr/gam002.CrossRefPubMed
32.
go back to reference di Giovine FS, Takhsh E, Blakemore AI, Duff GW: Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet. 1992, 1: 450-10.1093/hmg/1.6.450.CrossRefPubMed di Giovine FS, Takhsh E, Blakemore AI, Duff GW: Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet. 1992, 1: 450-10.1093/hmg/1.6.450.CrossRefPubMed
33.
go back to reference Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 1993, 91: 403-404. 10.1007/BF00217368.CrossRefPubMed Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 1993, 91: 403-404. 10.1007/BF00217368.CrossRefPubMed
34.
go back to reference Witkin SS, Gerber S, Ledger WJ: Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis. 2002, 34: 204-209. 10.1086/338261.CrossRefPubMed Witkin SS, Gerber S, Ledger WJ: Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis. 2002, 34: 204-209. 10.1086/338261.CrossRefPubMed
35.
go back to reference Pillay V, Gaillard MC, Halkas A, Song E, Dewar JB: Differences in the genotypes and plasma concentrations of the Interleukin-1 receptor antagonist in black and white South African asthmatics and control subjects. Cytokine. 2000, 12: 819-821. 10.1006/cyto.1999.0637.CrossRefPubMed Pillay V, Gaillard MC, Halkas A, Song E, Dewar JB: Differences in the genotypes and plasma concentrations of the Interleukin-1 receptor antagonist in black and white South African asthmatics and control subjects. Cytokine. 2000, 12: 819-821. 10.1006/cyto.1999.0637.CrossRefPubMed
36.
go back to reference Tishkoff SA, Williams SM: Genetic analysis of African populations: human evolution and complex disease. Nat Rev Genet. 2002, 3: 611-621. 10.1038/ni0702-611.CrossRefPubMed Tishkoff SA, Williams SM: Genetic analysis of African populations: human evolution and complex disease. Nat Rev Genet. 2002, 3: 611-621. 10.1038/ni0702-611.CrossRefPubMed
37.
go back to reference Kim SH, Mok JW, Kim HS, Joo CK: Association of -31T>C and -511 C>T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients. Mol Vis. 2008, 14: 2109-2116.PubMedPubMedCentral Kim SH, Mok JW, Kim HS, Joo CK: Association of -31T>C and -511 C>T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients. Mol Vis. 2008, 14: 2109-2116.PubMedPubMedCentral
38.
go back to reference Sainz J, Perez E, Gomez-Lopera S, Jurado M: IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level. J Clin Immunol. 2008, 28: 473-485. 10.1007/s10875-008-9197-0.CrossRefPubMed Sainz J, Perez E, Gomez-Lopera S, Jurado M: IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level. J Clin Immunol. 2008, 28: 473-485. 10.1007/s10875-008-9197-0.CrossRefPubMed
39.
go back to reference Liu K, Muse SV: PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics. 2005, 21: 2128-2129. 10.1093/bioinformatics/bti282.CrossRefPubMed Liu K, Muse SV: PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics. 2005, 21: 2128-2129. 10.1093/bioinformatics/bti282.CrossRefPubMed
40.
go back to reference Dudbridge F: Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 2008, 66: 87-98. 10.1159/000119108.CrossRefPubMedPubMedCentral Dudbridge F: Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 2008, 66: 87-98. 10.1159/000119108.CrossRefPubMedPubMedCentral
41.
go back to reference Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, et al: Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology. 2001, 121: 823-829. 10.1053/gast.2001.28000.CrossRefPubMed Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, et al: Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology. 2001, 121: 823-829. 10.1053/gast.2001.28000.CrossRefPubMed
42.
go back to reference Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093/bioinformatics/bth457.CrossRefPubMed Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093/bioinformatics/bth457.CrossRefPubMed
43.
go back to reference Roth SM: Perspective on the future use of genomics in exercise prescription. J Appl Physiol. 2008, 104: 1243-1245. 10.1152/japplphysiol.01000.2007.CrossRefPubMed Roth SM: Perspective on the future use of genomics in exercise prescription. J Appl Physiol. 2008, 104: 1243-1245. 10.1152/japplphysiol.01000.2007.CrossRefPubMed
44.
go back to reference Bray MS, Hagberg JM, Perusse L, Rankinen T, Roth SM, Wolfarth B, Bouchard C: The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Med Sci Sports Exerc. 2009, 41: 35-73.CrossRefPubMed Bray MS, Hagberg JM, Perusse L, Rankinen T, Roth SM, Wolfarth B, Bouchard C: The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Med Sci Sports Exerc. 2009, 41: 35-73.CrossRefPubMed
45.
go back to reference Rankinen T, Bray MS, Hagberg JM, Perusse L, Roth SM, Wolfarth B, Bouchard C: The human gene map for performance and health-related fitness phenotypes: the 2005 update. Med Sci Sports Exerc. 2006, 38: 1863-1888. 10.1249/01.mss.0000233789.01164.4f.CrossRefPubMed Rankinen T, Bray MS, Hagberg JM, Perusse L, Roth SM, Wolfarth B, Bouchard C: The human gene map for performance and health-related fitness phenotypes: the 2005 update. Med Sci Sports Exerc. 2006, 38: 1863-1888. 10.1249/01.mss.0000233789.01164.4f.CrossRefPubMed
46.
go back to reference Macarthur DG, North KN: Genes and human elite athletic performance. Hum Genet. 2005, 116: 331-339. 10.1007/s00439-005-1261-8.CrossRefPubMed Macarthur DG, North KN: Genes and human elite athletic performance. Hum Genet. 2005, 116: 331-339. 10.1007/s00439-005-1261-8.CrossRefPubMed
47.
go back to reference Riechman SE, Balasekaran G, Roth SM, Ferrell RE: Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol. 2004, 97: 2214-2219. 10.1152/japplphysiol.00491.2004.CrossRefPubMed Riechman SE, Balasekaran G, Roth SM, Ferrell RE: Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol. 2004, 97: 2214-2219. 10.1152/japplphysiol.00491.2004.CrossRefPubMed
48.
go back to reference Oberbach A, Lehmann S, Kirsch K, Krist J, Sonnabend M, Linke A, Toenjes A, Stumvoll M, Bluher M, Kovacs P: Long term exercise training decreases IL-6 serum levels in subjects with impaired glucose tolerance: effect of the -174G/C variant in interleukin-6 gene. Eur J Endocrinol. 2008, 159: 129-136. 10.1530/EJE-08-0220.CrossRefPubMed Oberbach A, Lehmann S, Kirsch K, Krist J, Sonnabend M, Linke A, Toenjes A, Stumvoll M, Bluher M, Kovacs P: Long term exercise training decreases IL-6 serum levels in subjects with impaired glucose tolerance: effect of the -174G/C variant in interleukin-6 gene. Eur J Endocrinol. 2008, 159: 129-136. 10.1530/EJE-08-0220.CrossRefPubMed
49.
go back to reference Halverstadt A, Phares DA, Roth S, Ferrell RE, Goldberg AP, Hagberg JM: Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training. Biochim Biophys Acta. 2005, 1734: 143-151.CrossRefPubMed Halverstadt A, Phares DA, Roth S, Ferrell RE, Goldberg AP, Hagberg JM: Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training. Biochim Biophys Acta. 2005, 1734: 143-151.CrossRefPubMed
50.
go back to reference Walston J, Arking DE, Fallin D, Li T, Beamer B, Xue Q, Ferrucci L, Fried LP, Chakravarti A: IL-6 gene variation is not associated with increased serum levels of IL-6, muscle, weakness, or frailty in older women. Exp Gerontol. 2005, 40: 344-352. 10.1016/j.exger.2005.01.012.CrossRefPubMed Walston J, Arking DE, Fallin D, Li T, Beamer B, Xue Q, Ferrucci L, Fried LP, Chakravarti A: IL-6 gene variation is not associated with increased serum levels of IL-6, muscle, weakness, or frailty in older women. Exp Gerontol. 2005, 40: 344-352. 10.1016/j.exger.2005.01.012.CrossRefPubMed
51.
go back to reference Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S, Biondi-Zoccai GG, Houser JE, Qureshi IZ, Ownby ED, et al: Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation. 2008, 117: 2670-2683. 10.1161/CIRCULATIONAHA.107.740233.CrossRefPubMed Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S, Biondi-Zoccai GG, Houser JE, Qureshi IZ, Ownby ED, et al: Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation. 2008, 117: 2670-2683. 10.1161/CIRCULATIONAHA.107.740233.CrossRefPubMed
52.
go back to reference Chennaoui M, Drogou C, Gomez-Merino D: Effects of physical training on IL-1beta, IL-6 and IL-1ra concentrations in various brain areas of the rat. Eur Cytokine Netw. 2008, 19: 8-14.PubMed Chennaoui M, Drogou C, Gomez-Merino D: Effects of physical training on IL-1beta, IL-6 and IL-1ra concentrations in various brain areas of the rat. Eur Cytokine Netw. 2008, 19: 8-14.PubMed
53.
go back to reference Carmichael MD, Davis JM, Murphy EA, Brown AS, Carson JA, Mayer EP, Ghaffar A: Role of brain IL-1beta on fatigue after exercise-induced muscle damage. Am J Physiol Regul Integr Comp Physiol. 2006, 291: R1344-1348.CrossRefPubMed Carmichael MD, Davis JM, Murphy EA, Brown AS, Carson JA, Mayer EP, Ghaffar A: Role of brain IL-1beta on fatigue after exercise-induced muscle damage. Am J Physiol Regul Integr Comp Physiol. 2006, 291: R1344-1348.CrossRefPubMed
54.
go back to reference Colotta F, Saccani S, Giri JG, Dower SK, Sims JE, Introna M, Mantovani A: Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J Immunol. 1996, 156: 2534-2541.PubMed Colotta F, Saccani S, Giri JG, Dower SK, Sims JE, Introna M, Mantovani A: Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J Immunol. 1996, 156: 2534-2541.PubMed
55.
go back to reference Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY: Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007, 356: 1517-1526. 10.1056/NEJMoa065213.CrossRefPubMed Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY: Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007, 356: 1517-1526. 10.1056/NEJMoa065213.CrossRefPubMed
56.
go back to reference Suzuki K, Peake J, Nosaka K, Okutsu M, Abbiss CR, Surriano R, Bishop D, Quod MJ, Lee H, Martin DT, et al: Changes in markers of muscle damage, inflammation and HSP70 after an ironman triathlon race. Eur J Appl Physiol. 2006, 98: 525-534. 10.1007/s00421-006-0296-4.CrossRefPubMed Suzuki K, Peake J, Nosaka K, Okutsu M, Abbiss CR, Surriano R, Bishop D, Quod MJ, Lee H, Martin DT, et al: Changes in markers of muscle damage, inflammation and HSP70 after an ironman triathlon race. Eur J Appl Physiol. 2006, 98: 525-534. 10.1007/s00421-006-0296-4.CrossRefPubMed
57.
go back to reference Andus T, Daig R, Vogl D, Aschenbrenner E, Lock G, Hollerbach S, Kollinger M, Scholmerich J, Gross V: Imbalance of the interleukin 1 system in colonic mucosa-association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2. Gut. 1997, 41: 651-657.CrossRefPubMedPubMedCentral Andus T, Daig R, Vogl D, Aschenbrenner E, Lock G, Hollerbach S, Kollinger M, Scholmerich J, Gross V: Imbalance of the interleukin 1 system in colonic mucosa-association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2. Gut. 1997, 41: 651-657.CrossRefPubMedPubMedCentral
58.
go back to reference Tountas NA, Casini-Raggi V, Yang H, Di Giovine FS, Vecchi M, Kam L, Melani L, Pizarro TT, Rotter JI, Cominelli F: Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology. 1999, 117: 806-813. 10.1016/S0016-5085(99)70338-0.CrossRefPubMed Tountas NA, Casini-Raggi V, Yang H, Di Giovine FS, Vecchi M, Kam L, Melani L, Pizarro TT, Rotter JI, Cominelli F: Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology. 1999, 117: 806-813. 10.1016/S0016-5085(99)70338-0.CrossRefPubMed
59.
go back to reference Crusius JB, Pena AS, Van Oosten BW, Bioque G, Garcia A, Dijkstra CD, Polman CH: Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet. 1995, 346: 979-10.1016/S0140-6736(95)91607-5.CrossRefPubMed Crusius JB, Pena AS, Van Oosten BW, Bioque G, Garcia A, Dijkstra CD, Polman CH: Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet. 1995, 346: 979-10.1016/S0140-6736(95)91607-5.CrossRefPubMed
60.
go back to reference Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF: Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J Bone Miner Res. 2000, 15: 402-414. 10.1359/jbmr.2000.15.3.402.CrossRefPubMed Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF: Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J Bone Miner Res. 2000, 15: 402-414. 10.1359/jbmr.2000.15.3.402.CrossRefPubMed
61.
go back to reference Kamangar F, Cheng C, Abnet CC, Rabkin CS: Interleukin-1B polymorphisms and gastric cancer risk-a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1920-1928. 10.1158/1055-9965.EPI-06-0267.CrossRefPubMed Kamangar F, Cheng C, Abnet CC, Rabkin CS: Interleukin-1B polymorphisms and gastric cancer risk-a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1920-1928. 10.1158/1055-9965.EPI-06-0267.CrossRefPubMed
Metadata
Title
Variable number of tandem repeat polymorphisms of the interleukin-1 receptor antagonist gene IL-1RN: a novel association with the athlete status
Authors
Sabina Cauci
Manuela Di Santolo
Kelli K Ryckman
Scott M Williams
Giuseppe Banfi
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2010
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-11-29

Other articles of this Issue 1/2010

BMC Medical Genetics 1/2010 Go to the issue